Gan & Lee Pharmaceuticals

Gan & Lee Pharmaceuticals is a company listed under the stock ticker 603087 (CN).

View the org chart displaying its 2 main executives

Most searched biographies at Gan & Lee Pharmaceuticals

• Nisa Leung, Director
• Christopher Yangan, Senior Vice President and Head of Global Quali...

Create your alert
to follow the executive moves at Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Gan & Lee Pharmaceuticals

Social media about Gan & Lee Pharmaceuticals

• Gan & Lee Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Gan & Lee Pharmaceuticals on LinkedIn, Twitter & YouTube

Call Gan & Lee Pharmaceuticals at +86 108...

View the org chart

Register to receive your alert

Report an error